# Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum

> **NCT07342608** · NA · NOT_YET_RECRUITING · sponsor: **MicroPort CRM** · enrollment: 450 (estimated)

## Conditions studied

- Bradycardia
- Left Bundle Branch Area Pacing
- Left Bundle Branch Pacing

## Interventions

- **DEVICE:** Use of LINEA cardiac pacing lead

## Key facts

- **NCT ID:** NCT07342608
- **Lead sponsor:** MicroPort CRM
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2027-01-31
- **Final completion:** 2030-04-30
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07342608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07342608, "Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07342608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*